CLINICAL_TRIALS
trial_result
· 2020-07-31
Clinical Trial Update: Celecoxib for Thyroid Eye Disease [Phase 2]
Summary
Phase 2 trial of celecoxib for Thyroid Eye Disease was terminated; results were posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Johns Hopkins University | Conditions: Thyroid Eye Disease | Phase 2 | Status: TERMINATED | Results posted: 2020-07-31